Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-003402
Filing Date
2020-02-05
Accepted
2020-02-05 19:34:55
Documents
2
Period of Report
2020-02-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5955
2 EX-24 DOCUMENT attachment1.htm EX-24 4146
  Complete submission text file 0000899243-20-003402.txt   11437
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Issuer) CIK: 0001745999 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BEAM THERAPEUTICS INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
Evans John M. (Reporting) CIK: 0001786304 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39208 | Film No.: 20580475